Organization and Basis of Presentation - Additional Information (Detail) - USD ($) |
6 Months Ended | |||||
|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Dec. 31, 2023 |
|
| Organization And Basis Of Presentation [Line Items] | ||||||
| Month and year of incorporation | 2007-01 | |||||
| Cash and cash equivalents | $ 12,059,072 | $ 13,596,600 | ||||
| Stockholders' equity | $ 4,374,492 | $ 5,841,215 | $ 7,038,010 | $ 2,664,958 | $ 3,497,169 | $ (2,579,537) |
| Common stock, par value | $ 0.0001 | $ 0.0001 | ||||
| Reverse stock split description | On May 22, 2024, the Company's stockholders granted the board of directors the authority to effect a reverse stock split of the Company's outstanding common stock. On July 31, 2024, the Company filed an amendment (the “Amendment”) to its amended and restated certificate of incorporation to effectuate a reverse stock split of the Company’s common stock. Pursuant to the Amendment, at the effective time of 12:01 a.m. Eastern Time on August 1, 2024, each twelve (12) shares of the Company’s common stock issued and outstanding was combined into one (1) validly issued, fully paid and non-assessable share of common stock (the “Reverse Stock Split”). The par value and the authorized shares of the Company's common stock were not adjusted as a result of the Reverse Stock Split. All issued and outstanding common stock, warrants to purchase common stock, options to purchase common stock, per-share data and related information have been retroactively adjusted to reflect the Reverse Stock Split for all periods presented. | |||||
| Eversana Agreement [Member] | ||||||
| Organization And Basis Of Presentation [Line Items] | ||||||
| Principal and interest on the loan | $ 7,400,000 | |||||
| Principal and interest on loan due period | 90 days |